Durolane – stabilized hyaluronic acid for single injection
The preparation is approved in the EU for the symptomatic treatment of mild to moderate pain associated with osteoarthritis of the ankle, shoulder, elbow, wrist and interphalangeal joints of the fingers, toes, temporomandibular and facet joints.
DUROLANE should not be used if you have an infection or skin disease at the injection site. DUROLANE has not been studied in pregnant or breast-feeding women or children.
Risks may include: transient pain, swelling and/or stiffness at the injection site.
symptomatic treatment of mild to moderate osteoarthritis of the knee and hip joints.
No known contraindications.